Show simple item record

dc.contributor.authorStene, Guro Birgitte
dc.contributor.authorHelbostad, Jorunn
dc.contributor.authorBalstad, Trude Rakel
dc.contributor.authorRiphagen, Ingrid Ingeborg
dc.contributor.authorKaasa, Stein
dc.contributor.authorOldervoll, Line Merete
dc.date.accessioned2017-12-19T13:36:11Z
dc.date.available2017-12-19T13:36:11Z
dc.date.created2013-11-22T08:28:10Z
dc.date.issued2013
dc.identifier.citationCritical reviews in oncology/hematology. 2013, 88 (3), 573-593.nb_NO
dc.identifier.issn1040-8428
dc.identifier.urihttp://hdl.handle.net/11250/2472976
dc.description.abstractCancer treatment and its side effects may cause muscle wasting. Physical exercise has the potential to increase muscle mass and strength and to improve physical function in cancer patients undergoing treatment. A systematic review was conducted to study the effect of physical exercise (aerobic, resistance or a combination of both) on muscle mass and strength in cancer patients with different type and stage of cancer disease. Electronic searches were performed up to January 11th 2012, identifying 16 randomised controlled trials for final data synthesis. The studies demonstrated that aerobic and resistance exercise improves upper and lower body muscle strength more than usual care. Few studies have assessed the effect of exercise on muscle mass. Most studies were performed in patients with early stage breast or prostate cancer. Evidence on the effect of physical exercise on muscle strength and mass in cancer patients with advanced disease is lacking. More exercise studies in patients with advanced cancer and at risk of cancer cachexia are warranted.nb_NO
dc.language.isoengnb_NO
dc.publisherElseviernb_NO
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 Internasjonal*
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/deed.no*
dc.titleEffect of physical exercise on muscle mass and strength in cancer patients during treatment : A systematic reviewnb_NO
dc.typeJournal articlenb_NO
dc.typePeer reviewednb_NO
dc.description.versionacceptedVersionnb_NO
dc.source.pagenumber573-593nb_NO
dc.source.volume88nb_NO
dc.source.journalCritical reviews in oncology/hematologynb_NO
dc.source.issue3nb_NO
dc.identifier.doi10.1016/j.critrevonc.2013.07.001
dc.identifier.cristin1068153
dc.description.localcode© 2013. This is the authors’ accepted and refereed manuscript to the article. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/nb_NO
cristin.unitcode194,65,30,0
cristin.unitcode194,65,15,0
cristin.unitcode194,65,20,0
cristin.unitnameInstitutt for nevromedisin og bevegelsesvitenskap
cristin.unitnameInstitutt for klinisk og molekylær medisin
cristin.unitnameInstitutt for samfunnsmedisin og sykepleie
cristin.ispublishedtrue
cristin.fulltextoriginal
cristin.qualitycode1


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivatives 4.0 Internasjonal